Mon, October 31, 2022

Michael Ulz Maintained (YMAB) at Hold with Decreased Target to $8 on, Oct 31st, 2022

Michael Ulz of Morgan Stanley, Maintained "Y-mAbs Therapeutics, Inc." (YMAB) at Hold with Decreased Target from $17 to $8 on, Oct 31st, 2022.

Michael, nor any peers, have made any analyst calls on YMAB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30